1) Terri B, Krastinova E, Marie I, et al:Management of noninfectious mixed cryoglobulinemia vasculitis:data from 242 cases included in the CryoVas survey. Blood 2012;119:5996-6004 2) Kidney Disease:Improving Global Outcomes (KDIGO):KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl 2008;109:S1-99 3) 川村明夫:冷却濾過.阿岸鉄三編,血液浄化療法,医学書院,東京,1996, pp.33-9 4) Terri B, Marie I, Lacraz A, et al:Non HCV-related infection cryoglobulinemia vasculitis:results from the French nationwide CryoVas survey and systematic review of the literature. J Autoimmun 2015;65:74-81 5) Stefanutti C, Vivensio A, DiGiamcomo S, et al:Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia. J Clin Apher 2009;24:241-6 6) 南康範,工藤正俊:C型肝炎ウイルス関連クリオグロブリン血管炎.BRAIN and NERVE 2018;70:133-7 7) Montero N, Fava A, Rodriguez, et al:Treatment for hepatitis C virus associated mixed cryoglobulinaemia. Cochrane Database Syst Rev 2018;5:CD011403 8) Roccatello D, Saadoun D, Ramos-Casals M, et al:Cryoglobulinaemia. Nat Rev Dis Primers 2018;4(1):11 9) Desbois AC, Cacoub P, Saadoun D:Cryoglobulinemia:An update in 2019. Joint Bone Spine 2019;86:707-13 10) Bhattarai M, Woytowitz DV, Kaldash H, et al:Recurrent mixed cryoglobulinemia (MCS):a case report and literature review. R I Med J 2015;98:33-7 11) Dammacco F, Sansonno D:Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. N Engl J Med 2013;369:1035-45 12) 上田恭典:クリオグロブリン血症へのアフェレシス療法.腎と透析2015;78:257-62 13) De Vita S, Quartuccio L, Isola M, et al:A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 2012;64:843-53 14) Auzerie V, Chiali A, Bussel A, et al:Leg ulcers associated with cryoglobulinemia:clinical study of 15 patients and response to treatment. Arch Drematol 2003;13:391-3 15) 長谷川みどり,稲熊大城,湯澤由紀夫:血管炎症候群に対する血漿交換療法.日本急性血液浄化化学会雑誌2017;8:21-6